Sex and Age Differences in the Association of Serum GFAP Levels with Cognitive Decline in Cognitively Unimpaired Individuals: Results from the A4 Study
These findings suggest that serum GFAP may serve as a biomarker for identifying CU women at greater risk of cognitive decline, underscoring the need for sex-specific strategies in AD risk assessment and prevention.
Authors
- Elham Ghanbarian
- Seyed ahmad Sajjadi (ORCID: https://orcid.org/0000-0001-5003-7889)
- Babak Khorsand
- Laura A. Rabin
- Ali Ezzati
- Richard B. Lipton
Institutions
- Albert Einstein College of Medicine (US)
- City University of New York (US)
- University of California, Irvine (US)
- Brooklyn College (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_103439
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00